Shah K - Search Results

1

Arming an Oncolytic Herpes Simplex Virus Type 1 with a Single-chain Fragment Variable Antibody against PD-1 for Experimental Glioblastoma Therapy.

Passaro C, Alayo Q, De Laura I, McNulty J, Grauwet K, Ito H, Bhaskaran V, Mineo M, Lawler SE, Shah K, Speranza MC, Goins W, McLaughlin E, Fernandez S, Reardon DA, Freeman GJ, Chiocca EA, Nakashima H. Passaro C, et al. Among authors: shah k. Clin Cancer Res. 2019 Jan 1;25(1):290-299. doi: 10.1158/1078-0432.CCR-18-2311. Epub 2018 Oct 2. Clin Cancer Res. 2019. PMID: 30279232 Free PMC article.

2

In vivo imaging of HIV protease activity in amplicon vector-transduced gliomas.

Shah K, Tung CH, Chang CH, Slootweg E, O'Loughlin T, Breakefield XO, Weissleder R. Shah K, et al. Cancer Res. 2004 Jan 1;64(1):273-8. doi: 10.1158/0008-5472.can-03-1123. Cancer Res. 2004. PMID: 14729634

3

MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas.

Corsten MF, Miranda R, Kasmieh R, Krichevsky AM, Weissleder R, Shah K. Corsten MF, et al. Among authors: shah k. Cancer Res. 2007 Oct 1;67(19):8994-9000. doi: 10.1158/0008-5472.CAN-07-1045. Cancer Res. 2007. PMID: 17908999

4

Human glioblastoma-derived cancer stem cells: establishment of invasive glioma models and treatment with oncolytic herpes simplex virus vectors.

Wakimoto H, Kesari S, Farrell CJ, Curry WT Jr, Zaupa C, Aghi M, Kuroda T, Stemmer-Rachamimov A, Shah K, Liu TC, Jeyaretna DS, Debasitis J, Pruszak J, Martuza RL, Rabkin SD. Wakimoto H, et al. Among authors: shah k. Cancer Res. 2009 Apr 15;69(8):3472-81. doi: 10.1158/0008-5472.CAN-08-3886. Epub 2009 Apr 7. Cancer Res. 2009. PMID: 19351838 Free PMC article.

5

A dual PI3K/mTOR inhibitor, PI-103, cooperates with stem cell-delivered TRAIL in experimental glioma models.

Bagci-Onder T, Wakimoto H, Anderegg M, Cameron C, Shah K. Bagci-Onder T, et al. Among authors: shah k. Cancer Res. 2011 Jan 1;71(1):154-63. doi: 10.1158/0008-5472.CAN-10-1601. Epub 2010 Nov 17. Cancer Res. 2011. PMID: 21084267

6

Encapsulated therapeutic stem cells implanted in the tumor resection cavity induce cell death in gliomas.

Kauer TM, Figueiredo JL, Hingtgen S, Shah K. Kauer TM, et al. Among authors: shah k. Nat Neurosci. 2011 Dec 25;15(2):197-204. doi: 10.1038/nn.3019. Nat Neurosci. 2011. PMID: 22197831 Free PMC article.

7

Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors.

Tamura K, Wakimoto H, Agarwal AS, Rabkin SD, Bhere D, Martuza RL, Kuroda T, Kasmieh R, Shah K. Tamura K, et al. Among authors: shah k. Mol Ther. 2013 Jan;21(1):68-77. doi: 10.1038/mt.2012.175. Epub 2012 Aug 28. Mol Ther. 2013. PMID: 22929661 Free PMC article.

8

Stem cells loaded with multimechanistic oncolytic herpes simplex virus variants for brain tumor therapy.

Duebgen M, Martinez-Quintanilla J, Tamura K, Hingtgen S, Redjal N, Wakimoto H, Shah K. Duebgen M, et al. Among authors: shah k. J Natl Cancer Inst. 2014 May 16;106(6):dju090. doi: 10.1093/jnci/dju090. Print 2014 Jun. J Natl Cancer Inst. 2014. PMID: 24838834

9

Encapsulated stem cells loaded with hyaluronidase-expressing oncolytic virus for brain tumor therapy.

Martinez-Quintanilla J, He D, Wakimoto H, Alemany R, Shah K. Martinez-Quintanilla J, et al. Among authors: shah k. Mol Ther. 2015 Jan;23(1):108-18. doi: 10.1038/mt.2014.204. Epub 2014 Oct 29. Mol Ther. 2015. PMID: 25352242 Free PMC article.

10

Stem Cell-Based Therapies for Cancer.

Bhere D, Shah K. Bhere D, et al. Among authors: shah k. Adv Cancer Res. 2015;127:159-89. doi: 10.1016/bs.acr.2015.04.012. Epub 2015 May 19. Adv Cancer Res. 2015. PMID: 26093900 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,339 results

Search Page